Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc > Some kind of update is required

<< Previous

Bullboard Posts

Next >>

Comment by NSX001on Feb 09, 2022 9:35am

86 Views

Post# 34411852

RE:RE:Some kind of update is required

Good morning Golddetector,

Why don't they just say why. Just a short message, you know, something like, due to issues at the test facility, or, due to delays with Health Canada & FDA replying because of Covid iduced staff shortages, I don't think anyone is going to jump all over them for it.

Three months without a word just isn't right, give us something to keep us beleiving in Tertra.

NSX001

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing